2002
DOI: 10.1016/s0161-813x(02)00082-7
|View full text |Cite
|
Sign up to set email alerts
|

Physostigmine and Hyoscine Improves Protection Against the Lethal and Incapacitating Effects of Nerve Agent Poisoning in the Guinea-Pig

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
35
0
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(38 citation statements)
references
References 29 publications
2
35
0
1
Order By: Relevance
“…Pretreatment with pyridostigmine prevents OP-induced irreversible AChE inhibition in the periphery, and it increases survival of animals acutely exposed to lethal doses of nerve agents, provided that atropine and oximes are administered promptly after an OP exposure (5,8,9). When used acutely before an OP exposure, reversible inhibitors of AChE that are capable of crossing the blood-brain barrier, including physostigmine, tacrine, and huperzine A (hereafter referred to as huperzine), afford better protection than pyridostigmine against OP toxicity, but generally this protection occurs at doses that produce significant incapacitation and central nervous system impairment (10-13).…”
mentioning
confidence: 99%
“…Pretreatment with pyridostigmine prevents OP-induced irreversible AChE inhibition in the periphery, and it increases survival of animals acutely exposed to lethal doses of nerve agents, provided that atropine and oximes are administered promptly after an OP exposure (5,8,9). When used acutely before an OP exposure, reversible inhibitors of AChE that are capable of crossing the blood-brain barrier, including physostigmine, tacrine, and huperzine A (hereafter referred to as huperzine), afford better protection than pyridostigmine against OP toxicity, but generally this protection occurs at doses that produce significant incapacitation and central nervous system impairment (10-13).…”
mentioning
confidence: 99%
“…For several years, 2 mg as the 'unit dose' of atropine in the MARK researchers in Israel, the UK and the Nether-I or ATNAA autoinjectors was established lands have demonstrated the effectiveness of because this amount of atropine can reverse the scopolamine or hyoscine as part of a pretreateffects of low or moderate exposures to nerve ment combination with the centrally active caragent. The associated side-effects of this dose bamate physostigmine against soman poisoning are well-tolerated, change in mental status is (Meshulam et al, 2001;Philippens et al, 2000;very unlikely and reasonable military perfor-Wetherell, 1994;Wetherell et al. 2002).…”
Section: Principles Of Treatment Ofmentioning
confidence: 96%
“…BChE can act as an endogenous scavenger for organophosphate compound, which is blocked by pyridostigmine. The inability of the compound to prevent central nervous system manifestations such as seizures may demand the inclusion of anticonvulsants into the treatment pattern [29,30] .…”
Section: Current Treatment Optionsmentioning
confidence: 99%